#UCSF Study

Unlocking the MS-EBV Connection: UCSF's Groundbreaking Study Reveals New Insights

A landmark study from UC San Francisco, published today, February 5, 2026, in Nature Immunology, offers compelling new evidence linking the Epstein-Barr Virus (EBV) to Multiple Sclerosis (MS). This research sheds light on how a common virus might trigger the autoimmune attack characteristic of MS, opening new avenues for treatment and prevention.